vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT)

Q: What does CUSIP 918385204 represent in this 13F holders report?

CUSIP 918385204 is the security identifier for VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share in Q3 2025?

23 institutional investors reported VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share for Q3 2025. Use the holders table for investor-level position and value details.

CUSIP: 918385204

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding: 3,964,740
Total 13F shares: 988,279
Share change: +401,136
Total reported value: $23,052,921
Price per share: $23.35
Number of holders: 23
Value change: +$9,364,357
Number of buys: 11
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP 918385204?
CUSIP 918385204 identifies VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2025
Previous quarter: Q2 2025

Recent filing periods for CUSIP 918385204:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Srinivas Akkaraju	3/4/5	Director	— mixed-class rows	6,591,443 mixed-class rows	$76,395,257	—	22 Sep 2025	3/4/5
Ronald O Perelman	3/4/5	10%+ Owner	— class O/S missing	36,519,212	$30,482,586	—	20 Dec 2021	3/4/5
Deepa Prasad	3/4/5	President and CEO, Director	— class O/S missing	2,498,635	$29,508,879	—	19 Oct 2021	3/4/5
Samsara BioCapital GP, LLC	3/4/5	10%+ Owner	— mixed-class rows	1,099,362 mixed-class rows	$14,038,836	—	05 Mar 2024	3/4/5
Invus Global Management, LLC	13D/G	Raymond Debbane	9.4%	393,098	$9,179,310	+$1,051,154	30 Sep 2025	13D/G
Rich S. Nelson	3/4/5	Acting Chief Executive Officer, Director	— class O/S missing	500,000	$5,905,000	—	03 Mar 2022	3/4/5
Trails Edge Capital Partners, LP	13D/G	—	9.9%	340,536	$5,108,040	$0	29 Aug 2025	13D/G
Samsara BioCapital, LLC	13F	Company	5.2%	206,784	$3,101,760	—	30 Jun 2025	13F
FMR LLC	13F	Company	4.5%	178,200	$2,626,668	—	30 Jun 2025	13F
BAKER BROS. ADVISORS LP	13F 3/4/5	Company · Director	2.5%	97,314	$1,459,710	—	30 Jun 2025	13F 3/4/5
Chandresh Harjivan	3/4/5	Director	— class O/S missing	75,000	$1,203,000	—	19 Jun 2023	3/4/5
Hersh Kozlov	3/4/5	Director	— class O/S missing	75,000	$1,203,000	—	19 Jun 2023	3/4/5
Howard L. Weiner	3/4/5	Director	— class O/S missing	75,000	$1,203,000	—	19 Jun 2023	3/4/5
John A. Fry	3/4/5	Director	— class O/S missing	75,000	$1,203,000	—	19 Jun 2023	3/4/5
Keith R. Harris	3/4/5	Director	— class O/S missing	75,000	$1,203,000	—	19 Jun 2023	3/4/5
Steven L. Tuch	3/4/5	Chief Financial Officer	— class O/S missing	74,659	$881,723	—	27 Feb 2024	3/4/5
VANGUARD GROUP INC	13F	Company	1.1%	43,175	$636,399	—	30 Jun 2025	13F
NORTHERN TRUST CORP	13F	Company	0.39%	15,287	$229,305	—	30 Jun 2025	13F
Fahed Al-Marzooqi	3/4/5	Director	— class O/S missing	13,555	$224,877	—	10 Jun 2025	3/4/5
MILLENNIUM MANAGEMENT LLC	13F	Company	0.38%	15,042	$221,719	—	30 Jun 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.32%	12,866	$189,676	—	30 Jun 2025	13F
Anne M. Phillips	3/4/5	Director	— class O/S missing	10,860	$180,167	—	10 Jun 2025	3/4/5
Daniel K. Spiegelman	3/4/5	Director	— class O/S missing	10,000	$165,900	—	10 Jun 2025	3/4/5
Connective Capital Management, LLC	13F	Company	0.24%	9,712	$145,680	—	30 Jun 2025	13F
BlackRock, Inc.	13F	Company	0.12%	4,827	$72,405	—	30 Jun 2025	13F
UBS Group AG	13F	Company	0.07%	2,847	$42,705	—	30 Jun 2025	13F
MORGAN STANLEY	13F	Company	0.02%	746	$11,190	—	30 Jun 2025	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	170	$2,550	—	30 Jun 2025	13F
Activest Wealth Management	13F	Company	0%	50	$750	—	30 Jun 2025	13F
CoreCap Advisors, LLC	13F	Company	0%	45	$675	—	30 Jun 2025	13F
Parallel Advisors, LLC	13F	Company	0%	38	$570	—	30 Jun 2025	13F
Sunbelt Securities, Inc.	13F	Company	0%	15	$207	—	30 Jun 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	12	$180	—	30 Jun 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	9	$135	—	30 Jun 2025	13F
Barry K. Brown	3/4/5	Chief Accounting Officer	— class O/S missing	4	$68	—	11 Apr 2025	3/4/5
SBI Securities Co., Ltd.	13F	Company	0%	2	$30	—	30 Jun 2025	13F
RAYMOND JAMES FINANCIAL INC	13F	Company	0%	1	$15	—	30 Jun 2025	13F
Strategic Wealth Partners, Ltd.	13F	Company	0%	1	$15	—	30 Jun 2025	13F
G42 Investments AI Holdings RSC Ltd.	3/4/5	Director, 10%+ Owner	— class O/S missing	10,386,274	—	—	31 May 2022	3/4/5
Hh Sheikh Tahnoon bin Zayed S. Al-Nahyan	3/4/5	10%+ Owner	— class O/S missing	10,386,274	—	—	31 May 2022	3/4/5

Institutional Holders of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) as of Q3 2025

As of 30 Sep 2025, vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 988,279 shares. The largest 10 holders included SAMSARA BIOCAPITAL, LLC, FMR LLC, Siren, L.L.C., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, MILLENNIUM MANAGEMENT LLC, Connective Capital Management, LLC, and BlackRock, Inc.. This page lists 23 institutional shareholders reporting positions in this security for the Q3 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

Q3 2025 holders

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 Value $	Q3 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.